Home > Publications > CBCRP Annual Reports — 1998 > Summary of Awards by Institution

Summary of Awards by Institution

Alta Bates Foundation	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Smith, Mary Increasing Breast Health Access for Women With Disabilities	3.0	$494,776	$9,367	$504,143

Beckman Research Institute of the City of Hope	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Chen, Shiuan Breast Cancer Prevention with Phytoestrogens in Grape Juice	3.0	$306,438	$232,893	$539,331

The Burnham Institute	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Baribault, Helene Role of Gamma-catenin in a Breast Cancer Mouse Model	2.0	$149,704	$142,219	$291,923
Ely, Kathryn Role of Rb Protein and Cell Cycle Defects in Breast Cancer	2.0	$145,321	$138,055	$283,376
Matsuzawa, Shu-ichi Siah-family Genes: Effectors of p53 in Breast Cancer	2.0	$69,820	$5,586	$75,406
Narisawa, Sonoko Understanding Breast Cancer Cell Metastasis to Bone	3.0	$224,210	$213,000	$437,210
Yamamoto, Fumiichiro Alteration of Developmental Genes in Breast Cancer	2.0	$150,000	$142,500	$292,500
Zeh, Karin Cell Adhesion Signaling Defects in Breast Cancer	2.0	$70,000	$5,600	$75,600
		$809,055	$646,960	$1,456,01

California Pacific Medical Center Research Institute	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Dairkee, Shanaz Molecular Mapping of Surgical Margins	2.0	$199,964	$88,028	$287,992
Drummond, Daryl A New System for Breast Cancer Drug Delivery	2.0	$69,991	$5,331	$75,322
		$269,955	$93,359	$363,314

Kaiser Foundation Research Institute	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Enger, Shelley Breast Tumor Markers and Response to Adjuvant Therapy	1.0	$73,934	$6,358	$80,292
Sternfeld, Barbara Epidemiology of Physical Activity and Ovarian Function	2.0	$149,482	$39,063	$188,545
		$493,371	$138,780	$632,151

La Jolla Institute for Experimental Medicine	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Sriramarao, Pragada Leukocyte Recruitment, Angiogenesis and Breast Cancer	2.0	$148,969	$155,844	$304,813

Lawrence Berkeley National Laboratory	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Barcellos-Hoff, Mary Helen Hormonal Regulation of TGF Beta During Mammary Development	3.0	$440,960	$319,928	$760,888
Itahana, Koji Novel Binding Functions of Mutant p53 in Breast Cancer Cells	2.0	$70,000	$0	$70,000
Kaufman, Paul Chromatin Regulation of Breast Cancer Cell Senescence	2.0	$150,000	$82,054	$232,054
Luo, Kunxin TGF-Beta Receptor Signaling and Breast Cancer	3.0	$224,246	$139,014	$363,260
Shyamala, G. Progesterone Receptor and Remodeling of Basement Membrane	1.0	$ 75,000	$49,412	$124,412
Stampfer, Martha Genes Involved in Immortalization of Human Mammary Cells	2.0	$150,000	$103,314	$253,314
VanBrocklin, Henry Development of EGFR-Based Imaging Agents for Breast Cancer	1.0	$50,000	$31,325	$81,325
		$1,160,206	$725,047	$1,885,253

Lyon-Martin Women's Health Services	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Roberts, Stephanie Breast Cancer Risk Factors: Lesbian and Heterosexual Women	3.0	$141,185	$28,238	$169,423

National Office of Samoan Affairs	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Luce-Aoelua, Pat Samoans and Cancer: Evaluation of a Culturally Appropriate Program	2.0	$319,172	$89,368	$408,540

Northern California Cancer Center	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Horn-Ross, Pamela Diet & Breast Cancer in the California Teachers Study Cohort	2.0	$110,933	$38,161	$149,094
Stewart, Susan Risk Notification for Women at High Risk for Breast Cancer	3.0	$499,007	$148,975	$647,982
		$609,940	$187,136	$797,076

SRI International	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Jong, Ling Dietary Indole Analogs for Breast Cancer Prevention	3.0	$224,995	$209,919	$434,914
Laderoute, Keith Novel Anti-vascular Agents for Breast Cancer Therapy	2.0	$199,998	$152,065	$352,063
		$424,993	$361,984	$786,977

Salk Institute for Biological Studies	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Louie, Gordon Heregulin-specific Diphtheria Toxin as a Cancer Therapy	3.0	$225,000	$195,975	$420,975
Ruffner, Heinz Biochemical and Functional Characterization of BRCA1	2.0	$70,000	$5,600	$75,600
		$295,000	$201,575	$496,575

San Francisco Department of Public Health	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Evins, Daramola Study of Inadequate Follow-up of Mammography Abnormalities	1.0	$74,980	$8,643	$83,623

Scripps Research Institute	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Ditzel, Henrik Targets of B Cell Infiltrate in Medullary Breast Cancer	2.0	$159,937	$119,953	$279,890
Lai, Cary The Role of a Newly Discovered Neuregulin in Breast Cancer	1.0	$49,984	$37,488	$87,472
Quaranta, Vito Regulation of Breast Epithelial Cell Motility by Proteases	3.0	$265,160	$198,870	$464,030
		475,081	$356,311	$831,392

Sidney Kimmel Cancer Center	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Lustgarten, Joseph Antibody-IL-2 Fusion Protein for Breast Cancer Immunotherapy	3.0	$224,100	$201,444	$425,544

Stanford University	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Rosen, Glenn A Novel Drug Induces Apoptosis in Breast Cancer Cells	2.0	$150,000	$81,490	$231,490
Spiegel, David Do Community Cancer Support Groups Reduce Physiologic Stress?	3.0	$496,143	$232,729	$728,872
		$646,143	$314,219	$960,362

University of California, Berkeley	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Nandi, Satyabrata Pregnancy Genes Associated With a Risk for Breast Cancer	3.0	$373,725	$0	$373,725

University of California, Davis	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Buonocore, Michael Measurement of Breast Tissue Viscoelasticity Using MRI	1.0	$49,984	$0	$49,984
Erickson, Kent Reduced Breast Cancer Metastasis by Conjugated Linoleic Acid	2.0	$199,629	$0	$199,629
Sawai, Earl Intracellular Signaling Pathways in Metastasis	1.0	$50,000	$0	$50,000
		$299,613	$0	$299,613

University of California, Irvine	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Mishra, Shiraz Samoans and Breast Cancer: Evaluating a Theory-Based Program	2.0	$168,955	$0	$168,955

University of California, Los Angeles	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Lindberg, Nangel Prediction of Compliance and Retention in High Risk	2.0	$69,600	$0	$69,600
Maly, Rose Improving Health-Related Quality of Life in Older Women after breast cancer	3.0	$417,677	$0	$417,677
Reuben, David Does Mobile Mammography Increase Screening in Older Women?	3.0	$499,982	$0	$499,982
		$987,259	$0	$987,259

University of California, San Diego	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Klonoff-Cohen, Hillary Timing of Breast Cancer Surgery, Menstrual Cycle & Prognosis	3.0	$520,075	$0	$520,075
Mitchell, Malcolm Breast Cancer Immunotherapy Using CD4+ Lymphocytes	2.0	$200,000	$0	$200,000
Vera, David Sentinel Node Detection via Targeted Fluorescence	1.0	$41,282	$0	$41,282
		$761,357	$0	$761,357

University of California, San Francisco	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Dibble, Suzanne Breast Cancer Risk Factors: Lesbian and Heterosexual Women	3.0	$ 186,214	$0	$186,214
Wrensch, Margaret Marin County Breast Cancer Study of Adolescent Risk Factors	1.0	$77,407	$0	$77,407
		$263,621	$0	$263,621

University of Southern California	Duration (Years)	Direct Costs	Indirect Costs	Total Costs
Feigelson, Heather Multi-ethnic Study of Genetic Control of Plasma Hormones	3.0	$214,254	$136,404	$350,658
Formenti, Silvia Biologic Determinants of Response to Paclitaxel & Radiation	3.0	$498,315	$318,302	$816,617
Hill, Deirdre Radiation, Reproductive & Menstrual Factors & Breast Cancer	2.0	$70,000	$5,600	$75,600
Markland, Francis Mechanism of Novel Anti-Angiogenic Therapy for Breast Cancer	2.0	$200,000	$124,300	$324,300
Ross, Ronald NCCC Breast Cancer Research Training Program	3.0	$314,877	$25,190	$340,067
Shames, Lisa Exercise and Risk of Breast Cancer Recurrence	2.0	$149,979	$95,795	$245,774
Ursin, Giske Oral Contraceptives, Hormonal Risk Factors and BRCA1	3.0	$1,041,683	$659,008	$1,700,691
		$2,489,108	$1,364,599	$3,853,707